Article By:
NASDAQ GlobeNewswire
Tuesday, January 24, 2017 9:19 AM EDT
Cascadian Therapeutics, Inc., today announced the pricing of the previously announced concurrent but separate underwritten offerings of 23,182,000 shares of its common stock at a price to the public of $3.30 per share.
In this article: CASC